1. Health Strategies Group
11/20/2018
Health Strategies Group
Medical Directors Describe the Majority of Current Relationships as Transactional or Collaborative
Out of 1,720 potential relationships with biopharmaceutical companies, MCO medical directors classify 23% as Collaborative and 25% as Transactional
Medical directors will continue to prioritize meeting with companies that have a strong relationship with their organization
Medical directors' view of the biopharmaceutical industry remains relatively unchanged from 2016
Slight variations in relationship distribution may reflect new biopharmaceutical companies added to the study and changes in the research panel
Request slides